1,4,7-triazacyclononane has been researched along with oxyquinoline in 1 studies
| Studies (1,4,7-triazacyclononane) | Trials (1,4,7-triazacyclononane) | Recent Studies (post-2010) (1,4,7-triazacyclononane) | Studies (oxyquinoline) | Trials (oxyquinoline) | Recent Studies (post-2010) (oxyquinoline) |
|---|---|---|---|---|---|
| 76 | 0 | 39 | 1,623 | 28 | 363 |
| Protein | Taxonomy | 1,4,7-triazacyclononane (IC50) | oxyquinoline (IC50) |
|---|---|---|---|
| Botulinum neurotoxin type A | Clostridium botulinum | 3.9 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 2.3736 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 2.9667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
1 other study(ies) available for 1,4,7-triazacyclononane and oxyquinoline
| Article | Year |
|---|---|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |